Investing.com -- Dyne Therapeutics, a biotechnology company, saw its shares rise by up to 10% after the market closed on Wednesday. The surge in stock price came as the company announced an investor ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
On Thursday, KeyBanc Capital Markets adjusted their financial outlook on DoorDash Inc. (NASDAQ: NASDAQ:DASH), increasing the price target from the previous $180.00 to a new figure of $225.00. The firm ...